Order Article Reprints

Gavriilaki E, Tsiftsoglou SA, Touloumenidou T, Farmaki E, Panagopoulou P, Michailidou E, Koravou E-E, Mavrikou I, Iosifidis E, Tsiatsiou O, et al. Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection. Current Issues in Molecular Biology. 2022; 44(7):2811-2824. https://doi.org/10.3390/cimb44070193

Gavriilaki, Eleni, Stefanos A. Tsiftsoglou, Tasoula Touloumenidou, Evangelia Farmaki, Paraskevi Panagopoulou, Elissavet Michailidou, Evaggelia-Evdoxia Koravou, Ioulia Mavrikou, Elias Iosifidis, Olga Tsiatsiou, and et al. 2022. "Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection" Current Issues in Molecular Biology 44, no. 7: 2811-2824. https://doi.org/10.3390/cimb44070193

Gavriilaki, E., Tsiftsoglou, S. A., Touloumenidou, T., Farmaki, E., Panagopoulou, P., Michailidou, E., Koravou, E.-E., Mavrikou, I., Iosifidis, E., Tsiatsiou, O., Papadimitriou, E., Papadopoulou-Alataki, E., Papayanni, P. G., Varelas, C., Kokkoris, S., Papalexandri, A., Fotoulaki, M., Galli-Tsinopoulou, A., Zafeiriou, D., ... Tragiannidis, A. (2022). Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection. Current Issues in Molecular Biology, 44(7), 2811-2824. https://doi.org/10.3390/cimb44070193